Drivelea

It is a fixed dose combination drug indicated for VIH positive patients and HLA-B*5701 negative patients, without hepatitis B virus.

Therapeutic Area
HIV + Infectology

Active Ingredient
Abacavir + Lamivudine + Dolutegravir

Line
HIV - Antivirals

Dosage forms
Dolutegravir 50mg + Abacavir 600mg + Lamivudine 300mg x 30 coated tablets.